Data gathered: May 15
AI Stock Analysis - Charles River Laboratories (CRL)
Analysis generated August 19, 2024. Powered by Chat GPT.
Charles River Laboratories International, Inc. (NYSE: CRL) is a global provider of essential products and services to expedite the discovery, early-stage development, and safe manufacture of novel drugs and therapeutics. They operate through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (MS). With an extensive portfolio of services, Charles River Laboratories aims to enhance the productivity and efficiency of pharmaceutical and biotechnology companies, government agencies, and leading academic institutions worldwide.
Stock Alerts - Charles River Laboratories (CRL)
 |
Charles River Laboratories | May 10 Rob Bresnahan (member of U.S. congress) is buying shares |
|
Charles River Laboratories | May 7 Price is up by 21.6% in the last 24h. |
|
Charles River Laboratories | April 17 Business Outlook among employees is down by 3.6% over the last month. |
|
Charles River Laboratories | April 14 Price is up by 7.2% in the last 24h. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Charles River Laboratories
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 555 | Sign up | Sign up | Sign up |
| Sentiment | 83 | Sign up | Sign up | Sign up |
| Webpage traffic | 202,000 | Sign up | Sign up | Sign up |
| Employee Rating | 62 | Sign up | Sign up | Sign up |
| Google Trends | 44 | Sign up | Sign up | Sign up |
| Patents | 6 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 2,395 | Sign up | Sign up | Sign up |
| Facebook Followers | 22,177 | Sign up | Sign up | Sign up |
| Instagram Followers | 5,310 | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 4 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 908 | Sign up | Sign up | Sign up |
| Twitter Followers | 9,170 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| Youtube Subscribers | 4,210 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 27 | Sign up | Sign up | Sign up |
| Linkedin Employees | 14,582 | Sign up | Sign up | Sign up |
About Charles River Laboratories
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment and Manufacturing Support.
| Price | $138.89 |
| Target Price | Sign up |
| Volume | 879,140 |
| Market Cap | $7.07B |
| Year Range | $99.75 - $220.69 |
| Dividend Yield | 0% |
| PE Ratio | 592.3 |
| Analyst Rating | 7% buy |
| Industry | Biotechnology |
In the news
 |
1,160 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Bought by Algert Global LLCMay 14 - ETF Daily News |
 |
Understanding Charles River (CRL) Reliance on International RevenueMay 12 - Yahoo |
|
William Blair Issues Positive Forecast for CRL EarningsMay 12 - ETF Daily News |
|
Charles River Laboratories to Present at Bank of America Health Care ConferenceMay 12 - Yahoo |
Transcript : Charles River Laboratories International, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-14-2025 08May 12 - Finnhub |
|
Charles River Laboratories International Inc. stock rises Monday, still underperforms marketMay 12 - MarketWatch |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 984M | 666M | 318M | 25M | 184M | 2.340 |
| Q4 '24 | 1B | 718M | 278M | -216M | -86M | 2.660 |
| Q3 '24 | 1.01B | 661M | 349M | 69M | 210M | 2.590 |
| Q2 '24 | 1.03B | 691M | 335M | 90M | 239M | 2.800 |
| Q1 '24 | 1.01B | 691M | 320M | 67M | 219M | 2.270 |
Insider Transactions View All
| LaPlume Joseph W filed to sell 20,013 shares at $162.5. February 21 '25 |
| Girshick Birgit filed to buy 55,058 shares at $164.6. February 21 '25 |
| FOSTER JAMES C filed to buy 183,639 shares at $165. February 21 '25 |
| WALLMAN RICHARD F filed to sell 12,386 shares at $216.5. November 12 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rob Bresnahan |
May 8, 25 | Buy | $15K - $50K |
| Julie Johnson |
Feb 13, 25 | Buy | $1K - $15K |
| Ro Khanna |
Dec 6, 24 | Buy | $1K - $15K |
Read more about Charles River Laboratories (CRL) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Charles River Laboratories?
The Market Cap of Charles River Laboratories is $7.07B.
What is Charles River Laboratories' PE Ratio?
As of today, Charles River Laboratories' PE (Price to Earnings) ratio is 592.3.
What is the current stock price of Charles River Laboratories?
Currently, the price of one share of Charles River Laboratories stock is $138.89.
How can I analyze the CRL stock price chart for investment decisions?
The CRL stock price chart above provides a comprehensive visual representation of Charles River Laboratories' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Charles River Laboratories shares. Our platform offers an up-to-date CRL stock price chart, along with technical data analysis and alternative data insights.
Does CRL offer dividends to its shareholders?
As of our latest update, Charles River Laboratories (CRL) does not offer dividends to its shareholders. Investors interested in Charles River Laboratories should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Charles River Laboratories?
Some of the similar stocks of Charles River Laboratories are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.